Key statistics dashboard for Avalo Therapeutics, Inc. (AVTX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit LIGHT.
Stock Data
| Price | $16.58 |
| Market Cap | $872M |
| Enterprise Value | $786.4M |
| Beta | 0.94 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -3.50 |
| Price / Book | 1.61 |
| P/S | 14771.82 |
| EV/EBITDA | -7.86 |
| EV/Sales | 13328.77 |
| EV/FCF | -11.85 |
| P/FCF | -13.13 |
| Earnings Yield | -13.88% |
| FCF Yield | -7.62% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -16861.02% |
| EBIT Margin | -169766.10% |
| EBITDA Margin | -169552.54% |
| Operating Margin | -154844.07% |
| Net Margin | -170055.93% |
| Return on Equity | -58.03% |
| Return on Assets | -20.44% |
| Return on Invested Capital | -19.44% |
| Return on Capital Employed | -19.45% |
Financial Health
| Current Ratio | 19.31 |
| Quick Ratio | 19.31 |
| Cash Ratio | 4.04 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.05% |
| Net Debt / EBITDA | 0.85 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -2.13 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 10.29 |
| Cash per share | 9.18 |
| FCF per share | -1.52 |
| Tangible Book Value per share | 10.05 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 8 |
| Hold | 1 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 10 |
| Avg rating (1-5) | 0.70 |
Related companies: AARD · BDTX · CHRS · CRBU · ENTA · EPRX · IVA
Explore sector: Healthcare · Biotechnology
More sections of AVTX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks